# ClinicalTrials.gov record history: NCT05478707

- Peptide profile: [dulaglutide](https://peptidescanner.com/peptides/dulaglutide/)
- Human timeline: https://peptidescanner.com/stories/clinicaltrials-gov-nct05478707-dulaglutide/
- JSON object: https://peptidescanner.com/clinical-trials-history/v1/trials/nct05478707.json
- Source observed: 2026-08-23T23:32:33.000Z
- Published by PeptideScanner: 2026-08-23
- Source observation SHA-256: `6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e`
- Object content SHA-256: `6c7946c2f0f7c52fed3d0ec38212f7f88fbcb83a5eb3e1dff27bcef37e6c4692`

## Reporting boundary

ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.

## Public history versions

| Version | Submitted | Last submitted QC | Status | Study type | Source-declared changed modules | Exact source | Record SHA-256 |
| ---: | --- | --- | --- | --- | --- | --- | --- |
| 1 | 2022-07-25 | 2022-07-25 | NOT_YET_RECRUITING | INTERVENTIONAL | None listed | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT05478707?a=1&tab=history) | `abd587627488cc9a98bd81eff8d285bb3aa6a91afb5d78fefe7b0c97e4146070` |
| 2 | 2022-10-31 | 2022-10-31 | NOT_YET_RECRUITING | INTERVENTIONAL | Study Description, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT05478707?a=2&tab=history) | `10e3d91773792a75a0c004de0bff7e2b3ec3dd11b7d7ebfc0f74bbb3d9830f2d` |
| 3 | 2023-11-03 | 2023-11-03 | RECRUITING | INTERVENTIONAL | Contacts/Locations, Eligibility, Study Description, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT05478707?a=3&tab=history) | `76c62ed5cba62eb2eac271f692c57b175a84c6d63c5a903e242987c708cc18c8` |
| 4 | 2024-11-08 | 2024-11-08 | RECRUITING | INTERVENTIONAL | IPDSharing, Oversight, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT05478707?a=4&tab=history) | `c27abe468fc786b4850ed198e997b51dce84519c9c3c6c25e11fed72e7dd000d` |
| 5 | 2025-12-09 | 2025-12-09 | SUSPENDED | INTERVENTIONAL | Arms and Interventions, Contacts/Locations, IPDSharing, Oversight, Study Description, Study Design, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT05478707?a=5&tab=history) | `16a2d5516f79433fcee98476e4c7760e8dce77724ca864873e17e0f7f5084b86` |
| 6 | 2026-04-03 | 2026-04-03 | SUSPENDED | INTERVENTIONAL | Oversight, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT05478707?a=6&tab=history) | `c8d39af26f5bd39b01555ba5da13f2a56e14dd4447ad7d7b9280624289b97aee` |
| 7 | 2026-08-10 | 2026-08-10 | RECRUITING | INTERVENTIONAL | Contacts/Locations, Eligibility, Sponsor/Collaborators, Study Identification, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT05478707?a=7&tab=history) | `a0abc778e5ee7de72ed1885655edf7c741c61ed48d73d7c5bb1ca896514cdffb` |